ATLANTA, GA--(Marketwire - December 03, 2007) - AtheroGenics, Inc. (NASDAQ: AGIX) today reported that it received a NASDAQ Staff Deficiency Letter on November 28, 2007 indicating that the Company fails to comply with the Market Value of Publicly Held Shares requirement for continued listing set forth in Marketplace Rule 4450(b)(1)(A). Furthermore, the notice indicated the Company does not comply with marketplace Rule 4450(b)(1)(B), which requires total assets and total revenue of $50 million each for the most recently completed fiscal year or two of the last three most recently completed fiscal years. The Company will be provided 30 calendar days to regain compliance with either of these two Rules. Should the Company not regain compliance by such date, it intends to file an appeal with the NASDAQ Listing Qualifications Panel.
